Sphingotec

SphingoTec GmbH

Founded 2002 · $29.2M raised

Founded
2002
Business Model
B2B
Total Funding
$29.2M
Last Round
$5.8M Series CAug 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

SphingoTec is a biomarker company in Hennigsdorf near Berlin, Germany, focused on licensing critical-care solutions for diagnosing, predicting, and monitoring acute medical conditions. It develops biomarkers to the commercial stage and partners with IVD companies to make them available on different IVD platforms. Its proprietary portfolio includes penKid for assessing kidney function in critical diseases and bio-ADM for assessing endothelial function in conditions including acute heart failure.

Summary

Sphingotec is a Biotech company, founded in 2002. It has raised $29.2M in total across 2 rounds, most recently a $5.8M Series C round in Aug 2024. Investors include HBM Healthcare Investments, Wellington Partners and Think.Health.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CAug 2024
$5.8M

Sign up to see all 2 events

Funding: Growth Equity through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sphingotec on Indexed.vc
<a href="https://indexed.vc/companies/sphingotec"><img src="https://indexed.vc/api/badge/company/sphingotec" alt="Sphingotec on Indexed.vc" width="260" height="76" /></a>